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Abstract
The toll-like receptors comprise one of the most conserved components of the innate immune system, signaling the
presence of molecules of microbial origin. It has been proposed that signaling through TLR4, which requires CD14 to
recognize bacterial lipopolysaccharide (LPS), may generate low-grade inflammation and thereby affect insulin sensitivity
and glucose metabolism. To examine the long-term influence of partial innate immune signaling disruption on glucose
homeostasis, we analyzed knockout mice deficient in CD14 backcrossed into the diabetes-prone C57BL6 background at 6 or
12 months of age. CD14-ko mice, fed either normal or high-fat diets, displayed significant glucose intolerance compared to
wild type controls. They also displayed elevated norepinephrine urinary excretion and increased adrenal medullary volume,
as well as an enhanced norepinephrine secretory response to insulin-induced hypoglycemia. These results point out a
previously unappreciated crosstalk between innate immune- and sympathoadrenal- systems, which exerts a major long-
term effect on glucose homeostasis.
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Introduction
The toll-like receptors (TLR) constitute the initial defense
against invading microorganisms, through the recognition of
microbial products and activation of innate immune signaling.
The recognition of gram-negative bacteria occurs through the
specific interaction bacterial lipopolysaccharide (LPS) with TLR4,
and the subsequent initiation of a pro-anti-inflammatory response
characterized by cytokine induction and secretion. CD14 is a
55 kD membrane-anchored glycoprotein that is absolutely
required for the productive interaction of LPS with TLR4 [1,2].
TLR4 and CD14 are predominantly expressed in immune cells
such as macrophages, which initiate the earliest responses to
invading microorganisms. However, TLR4 transcripts and protein
have been detected in other cell types, including endothelial and
neuroendocrine cells, [3,4,5], suggesting that cells other than
macrophages participate in innate immune signaling. Indeed, cells
in the para-ventricular hypothalamus [6,7,8,9], as well as cultured
hypothalamic neurons [7] respond very rapidly to LPS adminis-
tration in-vivo or in-vitro. This responsiveness of the hypothalam-
ic-pituitary and sympathoadrenal axes in response to microbial
invasion may play an important role in host defense by rapidly
triggering stress response pathways which in turn enhance
immune function [10].
The integrated response of the host to LPS can also be affected
by physiological modulation of the levels of CD14 and TLR4. For
example, TLR4 can be induced in human adipose tissue [11], and
its expression in macrophages can be induced several-fold by
oxidized LDL [12]. Increased expression of TLR4 and hypersen-
sitivity to LPS is also seen in response to aberrant TGFb signaling
[13]. A role for TLR4 and CD14 in mediating chronic low-level
inflammation has also been proposed. Obesity is often accompa-
nied by low-level inflammation, and this could potentially account
for the strong association between obesity and insulin resistance
[14,15,16,17,18,19,20,21,22,23]. The association between obesity
and inflammation could be due to many factors associated with
high fat diets, such as changes in gut microbiota, gut permeability,
or sensitization to bacterial products [24,25,26,27]. It has also
been proposed that saturated free fatty acids, which are elevated in
obesity, may generate insulin resistance through mechanisms that
require activation of TLR4 and downstream pro-inflammatory
signaling pathways [28,29].
In this context, it would be anticipated that suppression of
TLR4 signaling would reduce the deleterious metabolic effects
associated with obesity and consumption of high fat diet. However,
because physiological systems such as the HPA axis are also
responsive to LPS, the suppression of innate immune signaling
might influence metabolism in ways unrelated to insulin sensitivity.
To better understand the relationships between innate immune
signaling and metabolic homeostasis, we studied mice lacking LPS
binding capacity through knockout of CD14. These mice fail to
mount a pro-inflammatory response to LPS [30,31], and thus are
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protected from CD14/TLR4-dependent insulin resistance. In
spite of this protection, we find that CD14 knockout mice display
significantly impaired glucose tolerance at 6 and 12 months of age.
Interestingly, this is accompanied by altered basal adrenal tone
and hyper-responsiveness to hypoglycemia-induced sympatho-
adrenegic signaling. These results reveal a functional relationship
between innate immunity and sympatho-adrenal function, which
has a dominant impact on glucose homeostasis.
Materials and Methods
Materials
Recombinant human insulin was from Novo Nordisk (Novo
Nordisk Inc, Princeton, NJ); Fatty acid free bovine serum albumin
(Fraction V), oleic and palmitic acids were from Calbiochem.
Animals and animal care
All experiments involving vertebrate animals performed in the
work shown in this manuscript were described in protocol number
02-20-2009 and were specifically approved by the University of
Massachusetts Medical School Institutional Animal Care and Use
Committee, (Animal Welfare Assurance Number A3306-01).
CD14-ko mice have been backcrossed at least 12 generations to
the C57BL/6J background. C57Bl/6J mice were obtained from
the Jackson Laboratory at 6–11 weeks of age. All mice were
housed in ventilated polysulfone cages (Allentown Inc., Allentown,
NJ) in a strictly pathogen-free barrier facility maintained on a 12-
hour light/12-hour dark cycle. Mice had free access to autoclaved
water and food. Obesity was induced by a high fat diet consisting
of ,60% of calories from fat (TD93075; Harlan Teklad, Madison,
WI) starting at 11 weeks of age. Prior to 11 weeks, mice were fed
the standard pellet diet (LabDiet PicoLab 5053, Purina Mills, St.
Louis, MO). Animal weight and food consumption was measured
weekly for the duration of the experiment. Animals were fasted for
16–18 hours prior to sacrifice by cervical dislocation followed by
bilateral pneumothorax. Harvested tissues were immediately
frozen in liquid nitrogen and stored at 280uC or fixed in formalin
for immunohistochemical analysis.
Activity Measurements
Mouse movement was measured in custom-built activity
monitors using 880 nm near-infrared light emitting diodes with
a scan frequency of 125 Hz and a minimum detection interval of
0.040 seconds. Ambulatory activity was calculated by sequential
beam breaks, while stereotypic activity was calculated by multiple
breaks of the same beam. Mice were housed individually in their
native cages in parallel with controls with an initial 24-hour
acclimatization period and were monitored for at least 96 hours.
Body Fat Analysis
Fat tissue, lean tissue, and free fluid were measured by time
domain nuclear magnetic resonance (TD-NMR) using the Bruker
LF50 (Bruker Optics Inc, Billerica, MA) which utilizes relative
relaxation amplitude and duration to provide tissue contrast.
Glucose and Insulin Tolerance Tests
Glucose tolerance test was performed with intraperitoneal
injection of 10% w/v D-glucose in sterile water (2 g glucose/kg
body weight) following a 16–18 hour overnight fast. Whole blood
glucose values were measured using Ascencia Breeze (Bayer
Healthcare Diabetes Care Division, Tarrytown, NJ) or BD Logic
(Becton, Dickinson and Co, Franklin Lakes, NJ) glucose monitors
before and after the indicated times post challenge/injection.
Insulin tolerance tests were similarly performed with i.p. injection
of recombinant human insulin (0.75 U insulin/kg body weight;
Novolin R, Novo Nordisk Inc, Princeton, NJ) and blood glucose
measurements were done at the indicated times post challenge/
injection. Serum insulin was measured using ELISA (Millipore,
Billerica, MA). Where indicated, propranolol (2 mg/kg body
weight; Sigma, St. Louis, MO) or saline were injected 30 minutes
prior to insulin tolerance test protocol initiation.
Norepinephrine measurement
Norepinephrine was measured according to manufacturer’s
protocol. In short, plasma noradrenaline was extracted with a cis-
diol affinity gel, acylated to N-acylnoradrenaline, converted
enzymatically to N-acylnormetanephrine, and quantified in a
competitive immunoassay (Alpco Diagnostics, Salem, NH).
Serum Lipid Analyses
Serum was collected following 9 hour fast via retro-orbital
bleeding. Colorimetric analyses were employed to measure total
cholesterol (Wako Diagnostics, Richmond, VA), triglyceride
(Sigma, St. Louis, MO), and non-esterified fatty acid (Wako
Diagnostics) according to manufacturer’s protocol.
Adrenal Gland dissection and size analysis
The ventro-medial adrenal surface was marked with surgical ink
to maintain orientation. Adrenal glands were removed under a
dissecting microscope with liberal margins to prevent tissue
distortion and were immediately fixed in Bouin’s solution for
8 hours followed by overnight washing. Tissue was embedded in
paraffin and serially sectioned at 8 um intervals. Images (every
10th section starting from the first section) were captured with a
Zeiss Axiovert 200 inverted microscope (Thornwood, NY).
Other methods
C57Bl/6 mice (6–10 weeks of age) were intraperitoneally (i.p.)
injected with 4% thioglycollate (Sigma). After four days the
animals were euthanized and the peritoneum was flushed with
sterile PBS. The peritioneal exudate cells (PECs) were washed and
resuspended in DMEM with 10% fetal bovine serum (HyClone),
and 0.1% Pen/Strep (Cellgro). Cells were counted using a
hemacytometer and plated in a 96-well flat bottom plate at a
final concentration of 26105 cells/200 mL. Palmitic and Oleic
acids were conjugated to BSA (fatty acid free, Calbiochem) at a
molar ratio of 2:1. Cells were stimulated with lipids or BSA alone
at (1, 5, 10, 20, and 50 mLs) with and without phenol purified LPS
(1–100 ng/mL) (Sigma) for 16–20 hrs at 37uC and 5% CO2.
Supernatants were collected and an ELISA was performed for
mouse IL6 (BD Pharmingen) [32]. Oxygen consumption in
response to free fatty acids by cultured C2C12 myotubes was
done using a fluorescence-based oxygen consumption assay as
described previously [33]. ATP levels were measured using a
luciferase-based ATP determination assay (Molecular Probes).
Statistical Analysis
Statistical analysis employed two-tailed Student’s t tests or two-
way ANOVA followed by Bonferroni multiple comparisons test.
Statistics were performed using Prism Software (Graphpad, San
Diego, CA). Results are shown as mean 6 SEM unless otherwise
stated.
Results and Discussion
CD14-ko mice fed either normal (ND) or high fat (HFD) diet
gained weight at a similar rate to the C57Bl/6J control cohort
(Fig. 1A), and their weights were not statistically significantly
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different at the time of metabolic studies. Consistent with this
finding, NMR analyses of lean (Fig. 1B) and adipose (Fig. 1C) mass
demonstrated no genotype-specific differences between CD14-ko
mice from controls. Similarly, serum cholesterol, triglyceride, and
non-esterified fatty acid (NEFA) in CD14-ko mice were not
significantly different from wild type mice (Table 1). As total energy
expenditure and altered circadian rhythms can contribute to
metabolic variation in whole-body knockout mice, all mice studied
were individually housed in activity cages [34]. Total spontaneous
ambulatory movements and their circadian rhythmicity were
indistinguishable from age- matched controls (Fig. 1D,E).
Despite the lack of genotype-specific changes in overall body
composition in CD14-ko mice, glucose tolerance tests (GTT)
uncovered glucose intolerance. This phenotype was seen in 26-
week-old animals (Fig. 2A), and became more pronounced with
age, as seen in 52 week-old old mice (Fig. 2C). Glucose tolerance
was impaired in response to a HFD in wild-type animals, and was
further impaired in CD14-ko mice (Fig. 2A). We investigated
whether the glucose intolerance seen in these mice could be
attributed to insufficient insulin secretion or peripheral insulin
resistance. Fasting insulin levels were not significantly different
between genotypes (Table 1), although they increased by HFD in
Figure 1. Body weight, adiposity, and activity in wild-type and CD14-ko mice. (A) Growth curves of mice on ND and HFD; NMR analysis of
absolute lean mass (B) and fat mass (C) as a percentage of total dry mass. (D) Stereotypic movement determined by consecutive breaks in the same
beam path in 26 week old mice on ND. (E) Ambulatory activity as estimated by sequential beam breaks in the x-y axis over a 72-hour period after 24-
hour acclimatization in 26 week old mice on ND. Data presented in panels A–D are mean6SEM. (n = 8 mice per group, n = 4 mice for activity
measurements). Data in E is a representative experiment which was reproduced 4 times with similar results.
doi:10.1371/journal.pone.0029688.g001
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both genotypes. CD14-ko mice did not have defective insulin
secretion, as the time-weighted average insulin values following an
i.p. bolus of glucose (2 g/kg body weight) in these mice exceeded
that in wildtype controls (32136344 ng-min/mL in CD14-ko vs
1187682 ng-min/mL in control mice; p,0.005 respectively).
Thus, glucose intolerance in CD14-ko mice does not appear to be
due to impaired insulin secretion.
However, insulin tolerance tests (ITT) did demonstrate
genotype-related alterations (Fig. 2B,D). Specifically, while no
significant differences were observed during the first 15 min post
Table 1. Lipid Profile and Fasting Insulin of wild-type and CD14-ko mice at 52 weeks of age following 41 weeks of dietary
treatment.
Genotype Diet Cholesterol (mg/dL) Triglyceride (mmol/L) NEFA (mEq/L) Fasting Insulin (mEq/L)
WT Normal Chow 133.7612.1 1.6160.11 0.68860.16 0.7660.15
CD14-KO Normal Chow 127.268.6 1.6260.02 0.80460.05 1.1060.16
WT High Fat Chow 152.9614.7 1.5260.13 0.53060.08 1.5260.27a
CD14-KO High Fat Chow 140.1610.9 1.5460.03 0.53660.01 2.7260.55b
Values are expressed as mean 6 SEM, and significance calculated using ANOVA, n = 6–8.
a, p,0.01 relative to WT ND (normal diet);
b, p,0.01 relative to CD14-ko ND. NEFA, non-esterified fatty acid.
doi:10.1371/journal.pone.0029688.t001
Figure 2. Effects of disruption of the LPS signaling pathway on glucose tolerance. Glucose (A,C) and insulin (B,D) tolerance curves for 26-
week (A,B) and 52-week old (C,D) wild-type and CD14-ko mice on normal and HFD diets. Statistical differences between groups were determined by
2-way ANOVA, using Bonferroni multiple comparisons test. n = 8 mice per group. The values for basal glucose (mean and SEM in mg/dl, n = 8) for
wild-type and CD14-ko were: 26 weeks on ND: 8063 and 7764; 26 weeks on HFD: 10768 and 10864; 52 weeks on ND: 9261.5 and 10464; 52 weeks
on HFD: 11565 and 13265. None of the differences were significant as a function of phenotype.
doi:10.1371/journal.pone.0029688.g002
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insulin injection, the rebound phase of the ITT, which reflects the
counter regulatory response to hypoglycemia, was significantly
enhanced in CD14-ko compared to control mice (Fig. 2B). This
effect became more pronounced with age (Fig. 2D), and was most
pronounced in 52 week-old-mice fed a HFD (Fig. 2D) where,
despite similar declines in the first 30 min after insulin injection,
blood glucose levels of CD14-ko mice were significantly higher than
controls after 60 min, and significantly higher than values seen
before insulin injection after 90–120 min post-injection (14268%
and 12864% of initial glucose values at 120 min in 52-week-old
WT and CD14-ko mice on HFD; P values,0.0001 for CD14-ko vs
WT, n= 6).
Acute counter-regulatory pathways to hypoglycemia rely on
adrenal-derived catecholamines to inhibit insulin secretion and
peripheral glucose utilization, while promoting hepatic glycogen-
olysis and stimulating lipolysis [35,36]. To determine whether
adrenal catecholamines may explain the altered rebound phase in
the ITT in CD14-ko mice, we measured norepinephrine at
baseline, at 45 min post-injection to coincide with the inflection
in circulating glucose, and at 90 min post-injection when basal
glucose levels are re-established. At both 45 and 90 minutes post-
injection, norepinephrine levels in CD14-ko mice exceeded the
values seen in control mice (Fig. 3A). Moreover, increased tonic
catecholamine secretion could explain basal glucose intolerance in
Figure 3. Effects of disruption of the LPS signaling pathway on counter-regulatory response to hypoglycemia. Norepinephrine levels
in A) serum of wild type and CD14-ko 26 week old mice on ND following injection i.p. with insulin (1–1.5 U/kg body weight) *p,0.05, n = 6; B) urine
collected over a 24 h period ***p,0.001, n = 8). C) Area under the curve of the glucose excursions for WT and CD14-ko mice following saline or
propranolol (2 mg/kg of body weight) injection 30 minutes prior to insulin tolerance tests. **p,0.01 n = 4 for each group. Statistical differences were
determined by student t-tests.
doi:10.1371/journal.pone.0029688.g003
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these mice, as the level of norepinephrine found in urine collected
over a 24 hr period was significantly higher in CD14-ko mice
compared to controls (Fig. 3B). To further test the hypothesis that
a hyperactive adrenal response to hypoglycemia contributes to
impaired glucose homeostasis in CD14-ko mice, mice were treated
with the b-adrenergic receptor antagonist propranolol prior to
insulin administration. Pre-treatment with propranolol mitigated
the excess glucose production in response to insulin-induced
hypoglycemia in CD14-ko mice (Fig. 3C).
To search for additional evidence for an effect of CD14
depletion on adrenal function that could underlie the observed
alteration in sympathoadrenal response to hypoglycemia seen in
CD14-ko mice, we analyzed the morphology of their adrenal
glands. Adrenal glands from 5 mice from each genotype were
excised, fixed and serially sectioned at 8 um intervals (Fig. 4A).
Every 10th section was photographed (Fig. 4B), and the areas of
the whole adrenal and of the medulla in each section were
measured. These were summed to obtain a direct estimate of total
adrenal and adrenal medullary volume (Fig. 4C,D). This
morphometric method was advantageous in that it eliminated
variation due to extraneous tissue associated with the gland during
dissection. While the total adrenal volume of CD14-ko mice,
assessed by the sum of area of all sections, was not different from
WT mice, (Fig. 4C), the associated adrenal medullary volume was
significantly larger (Fig. 4D). Strain-associated variation in adrenal
volume has been documented [37]. However, the mice used in
these studies were backcrossed for more than 12 generations,
making it unlikely that strain-related factors account for the
differences observed.
The results presented here suggest that mice lacking a functional
LPS signaling pathway become glucose intolerant due to a tonic
effect of innate immune signaling to suppress the sympathoadrenal
axis, suppressing the production of norepinephrine by the medulla
or sympathetic nerve terminals, which produce the majority of
norepinephrine in the mouse [38]. The importance of the
sympathoadrenal axis on both glucose homeostasis and innate
immune signaling is well documented. Insulin sensitivity and
glucose uptake are normalized in ob/ob mice by adrenalectomy
[39,40,41]. In humans, adrenal hyperactivity in Cushing’s disease
is marked by hyperglycemia and adrenal insufficiency in Addison’s
disease is marked by hypoglycemia. Thus, enhanced adrenal tone
leads to hyperglycemia, through the activation of gluconeogenesis
Figure 4. Effects of disruption of the LPS signaling pathway on adrenal gland morphology. A) Adrenal glands were excised, fixed and
serially sectioned, and representative sections of a gland from a WT and a CD14-ko mouse are shown. The medulla is outlined by the slashed line. B)
Every 10th section was photographed, and in each image the entire gland was pseudocolored yellow, and the medulla was pseudocolored orange.
The sum of the areas of all sections were used to estimate total (C) and medullary (D) adrenal volumes in the glands from each genotype. *p,0.05
determined by student t-test, n = 4 adrenal glands per group.
doi:10.1371/journal.pone.0029688.g004
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by glucocorticoids, as well as by the sustained counter-regulatory
mechanisms mediated by norepinephrine.
Adrenal tone also plays an important role in innate immune
signaling. Adrenalectomy results in dramatic hypersensitivity to
LPS [42,43], possibly due at least in part to impairment in
catecholamine-mediated protection from LPS-induced hypoglyce-
mia [44,45]. Also, LPS administration leads to a rapid induction of
glucocorticoid production, which is impaired by TLR4 ablation
[46,47], and which is thought to provide a counter regulatory
response to mitigate exaggerated inflammatory responses to
infection [48,49]. Because of the strong suppressive effect of
catecholamines on LPS-induced inflammatory and metabolic
responses, a counter-regulatory input in which CD14/TLR4
signaling might exert a tonic suppression of adrenergic tone might
be necessary to maintain adequate innate immune responsiveness.
This may be the basis of the phenotype reported in this
manuscript, where absence of CD14, which is expected to impair
TLR4 signaling, causes enhanced medullary adrenal output.
Several studies have reported that deletion of TLR4 amelio-
rates insulin resistance produced by a high fat diet
[28,29,50,51,52,53,54], raising the question of why in our studies
CD14-ko mice display enhanced insulin resistance. The ameliora-
tion of insulin resistance in TLR4-deficient mice has been
interpreted to reflect a direct activation of TLR4 by saturated
fatty acids present in the diet. However, the lack of direct
interaction between the extracellular domain of TLR4 and
saturated fatty acids suggests alternative possibilities [55,56].
One such possibility may be that some high fat diets may enhance
the levels or activity of natural TLR4 ligands such as LPS, for
example through changes in gut permeability, microbiota
composition, or metabolic endotoxemia [25,26,57]. Thus, high-
fat diets could produce insulin resistance through at least two
concurrent mechanisms; first, by increasing LPS levels or
sensitivity to LPS, and second, through direct impairment of
insulin signaling pathways by excess free fatty acids [58,59], which
may be enhanced by tonic TLR4 activity. Depending on the
relative predominance of these mechanisms, ablation of TLR4
signaling would result in greater or lesser amelioration of HFD
induced insulin resistance. This model could explain the results
presented here where the absence of CD14 in extensively
backcrossed C57Bl6 mice raised and fed in strict pathogen-free
conditions does not ameliorate HFD-induced insulin resistance.
This model would also predict that the effects of fatty acids to
induce inflammatory responsiveness in macrophages would be
negligible compared to those induced by LPS. To test this directly,
we compared the induction of IL6 protein secretion by primary
macrophages in response to fatty acids and LPS. As expected,
secretion of IL6 by peritoneal macrophages was potently
stimulated by LPS (Fig. 5A), and this effect was absent in
macrophages obtained from CD14-ko mice. However, significant
IL6 secretion in response to palmitic acid, oleic acid or both could
not be detected in this assay, indicating that the magnitude of the
effect is very small compared to that of LPS. These fatty acids were
functional, as they induced a potent increase in oxygen
consumption when added to cultured myocytes, stemming from
their entry into the beta-oxidation pathway (Fig. 5B). Also, at high
concentrations, palmitic acid had toxic effects on macrophages,
reflected by a gradual decline in ATP levels over time (Fig. 5C).
These results confirm that LPS activation of TLR4 is much more
potent that its possible activation by fatty acids, consistent to that
seen by others [55,56]. Under our experimental conditions the
impairment of glucose homeostasis due to lack of CD14/TLR4
signaling overrides the small beneficial effects that might ensue
from the mitigation of non-LPS induced pro-inflammatory
signaling.
In human populations, high TLR expression is associated with
greater inflammatory responses [60]. Conversely, TLR4 polymor-
phisms (Asp299Gly) that confer decreased responsiveness to LPS
[61,62] increase susceptibility to infection [63,64]. These poly-
morphisms are strongly associated with a decreased susceptibility
Figure 5. Effect of free fatty acids on peritoneal macrophages. A) IL6 secretion from peritoneal macrophages obtained from wild type or
CD14-ko mice incubated in the absence or presence of the indicated concentrations of BSA alone, BSA-conjugated fatty acids, or LPS in the presence
of increasing concentrations of palmitic acid. B) Oxygen consumption by C2C12 cells incubated in the absence or presence of the indicated
concentration of BSA-conjugated fatty acids, C) ATP levels in peritoneal macrophages obtained from wild type mice incubated in the absence or
presence of the indicated concentrations of BSA alone or BSA-conjugated fatty acids. Shown are the means of duplicates from representative
experiments which were repeated a minimum of three times with similar results.
doi:10.1371/journal.pone.0029688.g005
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to atherosclerosis [65], consistent with the possibility that the
decrease in chronic inflammation due to hyporesponsive alleles
suppresses atherogenesis. Interestingly, these same polymorphisms
are associated with increased insulin levels, decreased insulin
sensitivity and family history of diabetes [66]. In large cross
sectional studies the association of these TLR4 alleles with
decreased insulin sensitivity persisted when corrected for body
fat [67]. Whether these polymorphisms in humans are associated
with altered adrenal tone is not known, but they are consistent
with our findings of impaired glucose tolerance in animals
deficient in innate immune inflammatory signaling. Future studies
designed to address the potential role of the LPS signaling pathway
in modulating adrenal tone in humans will be required to establish
the significance of the results presented here to human metabolic
disease.
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